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Mapping  Trait  Genes  in  Dogs.  Using  the  Dog  as  a  Model 
Organism 
Abstract 
Understanding the genetic background of a given phenotypic trait or disease has 
long intrigued scientists. Model organisms can be employed when it is not feasible 
or possible to find trait causality in human cohorts. This thesis reports the mapping 
of both a phenotypic trait (white spotting) and a disease (sensory ataxic neuropathy) 
in dogs, and in doing so highlights the potential of the dog as a model organism for 
mapping traits of relevance to human health and biology.  
For  white  spotting,  a  two-stage  mapping  approach  was  used  to  identify  an 
associated  genomic  region,  which  contained  only  the  microphtalmia-associated 
transcription factor  (MITF) gene. Stage 1: a genome-wide association analysis in a 
single breed, taking advantage of the extensive within breed linkage disequilibrium 
(LD) and long haplotypes, identified a discrete region of approximately 1 Mb. Stage 
2: finemapping in an additional breed presenting the same phenotype, exploiting 
the  short  LD and haplotypes  shared  across dog  breeds, was used to narrow the 
region to about 100 kb. We functionally evaluated two candidate polymorphisms 
associated with MITF, a SINE insertion and a length polymorphism upstream of the 
melanocyte-specific transcription start site of MITF. The data indicated that both 
polymorphisms affect transcription from the MITF-M promoter. 
Sensory ataxic neuropathy (SAN) is a neurological disorder affecting a specific 
maternal lineage of Golden Retrievers. We identified a one base pair deletion in 
mitochondrial  tRNA
Tyr  and  through  biochemical  analyses  of  mitochondria  and 
functional studies of the deletion, confirmed causality and the mitochondrial origin 
of SAN. This is one of the first mitochondrial disorders identified in dogs and we 
additionally developed a genetic test for the public to allow for the elimination of 
the disease from this breed. 
The genetic and functional analyses of both white spotting coat colour and SAN 
in dogs, which are controlled by mutations of the two different genomes, clearly 
demonstrate the utility of the canine model and establish a new role for man's best 
friend.  
 
Keywords: dog, model organism, association mapping, white spotting locus, MITF, 
mitochondrial disorder, sensory ataxic neuropathy, tRNA
Tyr 
Author’s address: Izabella Baranowska Körberg, SLU, Department of Animal 
Breeding and Genetics, P.O. Box 597, 751 24 Uppsala, Sweden  
E-mail: Izabella.Baranowska@slu.se  4 
   5 
 
Contents 
List of Publications  7 
Related Work by the Author  8 
Abbreviations  9 
Introduction  11 
Genetic trait mapping  12 
  Genetic markers  12 
  Linkage analysis and whole-genome association mapping  12 
  Utility of LD and haplotype blocks in genome-wide association    
  studies in human populations  15 
  Characteristics of isolated populations  15 
  Sources to false-positive associations  16 
Genetics of mitochondrial disorders  17 
   Disease-causing polymorphisms of the mitochondrial genome  17 
  Three major aspects by which mitochondrial and nuclear genetics    
  differ  19 
  Identifying the genetic origin of a mitochondrial disorder  20 
  Assessing mitochondrial mutation causality  21 
The dog as a model in genetic trait mapping  21  
  Population history of the domestic dog  21 
  Exploring the potential of the dog in whole-genome mapping studies  22 
Aims of this Thesis  25 
Present Studies  27 
 
MAPPING TWO TRAITS CONTROLLED BY TWO DIFFERENT GENOMES   
 
White spotting locus - proof-of-principle study (Papers I and III)  27  
Background  27  
Results and Discussion  28  
  Brief summary of canine SNP arrays and assessment of LD and    
  haplotype blocks  28 
  White spotting locus successfully mapped with a two-stage 
approach  28   6 
  Candidate mutations in MITF  31 
  Reporters suggest complex regulation of MITF  33  
  Concluding remarks of white spotting locus and MITF  36 
Future prospects  37  
  Future studies of MITF  37 
  Challenges and potential solutions in genetic trait mapping in    
  dogs  39 
 
Sensory ataxic neuropathy - a mitochondrial disorder in dogs (Paper II)  41 
Background  41 
Results and Discussion  41  
  Pedigree analysis and candidate mutation suggest mitochondrial   
  origin of SAN  41 
  Evaluation of methods for quantification  42 
  Assessment of mutant load and functional evaluation of    
  candidate deletion  43 
  Functional and morphologic analyses of mitochodria  45 
  Concluding remarks of SAN  46 
Future prospects  47  
  Challenges with mitochondrial disorders and future of SAN  47 
 
Populärvetenskaplig sammanfattning  49  
  Bakgrund  49 
  Hunden som modelldjur  49 
  Delarbete 1 & 3  50 
  Delarbete 2  51  
  Slutsats  51 
References  53 
Acknowledgements  65 
  
 
7 
List of Publications 
This thesis is based on the work contained in the following papers, which 
are referred to by Roman numerals in the text: 
I  Karlsson, E. K., Baranowska, I., Wade, C. M., Salmon Hillbertz, N. 
H. C., Zody, M. C., Anderson, N., Biagi, T. M., Patterson, N., 
Rosengren Pielberg, G., Kulbokas III, E. J., Comstock, K. E., Keller, E. 
T., Mesirov, J. P., von Euler, H., Kämpe, O., Hedhammar, Å., Lander, 
E. S., Andersson, G., Andersson, L. & Lindblad-Toh, K. (2007). Efficient 
Mapping of Mendelian Traits in Dogs Through Genome-Wide 
Association. Nature Genetics 39(11), 1321-1328. 
II  Baranowska, I., Hultin Jäderlund, K., Nennesmo, I., Holmqvist, E., 
Heidrich, N., Larsson, N.-G., Andersson, G., Wagner, E. G. H., 
Hedhammar, Å., Wibom, R. & Andersson, L. (2009). Sensory Ataxic 
Neuropathy in Golden Retriever Dogs Is Caused by a Deletion in the 
Mitochondrial tRNA
Tyr Gene. PLoS Genetics 5(5), e1000499. 
doi:10.1371/journal.pgen.1000499 
III Baranowska Körberg, I., Zhang X., Rosengren Pielberg, G., 
Gustafson, U., Karlsson, E. K., Hedhammar, Å., Lindblad-Toh, K., 
Andersson, G. & Andersson, L. Functional Studies of Sequence 
Polymorphisms at the MITF Locus Associated with White Spotting in 
Dogs. (manuscript).  
Papers I and II are reproduced with the permission of the publishers.  
 
8 
Related Work by the Author 
(Not included in the thesis) 
 
Lindqvist, C., Janczak, A. M., Nätt, D., Baranowska, I., Lindqvist, N., 
Wichman, A., Lundeberg, J., Lindberg, J., Torjesen, P. A. & Jensen, P.  
(2007). Transmission of Stress-Induced Learning Impairment and Associated 
Brain Gene Expression from Parents to Offspring in Chickens. PLoS ONE 
2(4), e364. doi:10.1371/journal.pone.0000364 
 
Awano, T., Johnson, G. S., Wade, C. M., Katz, M. L., Johnson, G. C., 
Taylor, J. F., Perloski, M., Biagi, T., Baranowska, I., Long, S., March, P. 
A., Olby, N. J., Shelton, G. D., Khan, S., O'Brien, D. P., Lindblad-Toh, K. 
&  Coates,  J.  R.  (2009).  Genome-Wide  Association  Analysis  Reveals  a 
SOD1  Mutation  in  Canine  Degenerative  Myelopathy  That  Resembles 
Amyotrophic Lateral Sclerosis. Proceedings of the National Academy of Science of 
the Unites States of America 106(8), 2794-2799. 
 
Hultin Jäderlund, K., Baranowska Körberg, I. & Nødtvedt, A. (2011). 
Inherited polyneuropathy in the Leonberger Breed; Pedigree Data Indicates 
a  Major  Risk  Factor  on  X-Chromosome.  Journal  of  Veterinary  Internal 
Medicine (Accepted).  
 
9 
Abbreviations 
ALS  amyotrophic lateral sclerosis 
ATP  adenosine-5'-triphosphate 
BAC  bacterial artificial chromosome 
bp  base pair 
CNS  central nervous system 
CNV  copy number variant 
COX  cytochrome c  
DNA  deoxyribonucleic acid 
ECM  encephalomyopathy 
FBSN  familial bilateral striatial necrosis 
Gb  gigabases 
GWAS  genome-wide association study 
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LD  linkage disequilibrium 
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LpL  long Lp 
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LS  Leigh's syndrome 
MAF  minor allele frequency 
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Mb  megabases 
MELAS  mitochondrial encephalomyopathy, lactic acidosis and 
stroke-like episodes 
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MITF  microphtalmia-associated transcription factor  
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mtDNA  mitochondrial DNA 
NARP  neuropathy ataxia and retinitis pigmentosa 
nDNA  nuclear DNA 
PCR  polymerase chain reaction 
PEO  progressive external ophthalmoplegia 
PPK  palmoplantar keratoderma 
qOLA  quantitative oligonucleotide ligation assay 
RLU  relative luciferase unit 
SAN  sensory ataxic neuropathy 
SDH  succinate dehydrogenase 
SIDS  sudden infant death syndrome 
SINE 
SINEC-Cf 
short interspersed nucleotide element 
canine-specific SINE 
SLE  systemic lupus erythematosus 
SLU  Swedish University of Agricultural Sciences 
SNP  single nucleotide polymorphism 
tRNA  transfer ribonucleic acid 
tRNA
Cys  tRNA
Cysteine 
tRNA
Gln  tRNA
Glutamine 
tRNA
Tyr  tRNA
Tyrosine 
wt  wild type 
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Introduction 
The  recent  development  of  nucleotide  sequencing  technologies  and 
bioinformatics  has  revolutionized  biology.  The  release  of  high  quality 
genome sequences for a variety of species enables scientists to explore the 
field of genomics and genetics like never before, including the fascinating 
and often challenging world of genetic trait mapping. Genetic mapping is 
the first step in understanding the molecular etiology of a given phenotypic 
trait  or  disease.  Useful  tools  for  further  genetic  dissection  include,  for 
example, next-generation sequencing (Schuster, 2008) allowing for efficient 
mutation detection, maps of evolutionary conservation (Miller et al., 2007), 
and  also  databases  containing  information  about  different  aspects  of  cell 
biology, such as tissue-specific gene expression and cellular pathways. In vivo 
models,  both  cell  culture  and  non-human  vertebrates,  are  crucial  to  the 
process  of  understanding  the  biological  mechanisms  and  defining  the 
functional  roles  of  the  causative  mutations  behind  phenotypic  traits  and 
diseases.  The  current  resources,  and  many  more  within  reach,  provide 
endless possibilities for researchers. Hence, this truly is the golden age of 
genetics.  
  The two most frequently used mammalian species for genetic studies of 
phenotypic  traits  and  diseases  are  humans  and  mice.  However  domestic 
animals,  such  as  the  horse,  chicken,  dog  and  pig,  have  also  been  used 
successfully both for mapping specific production traits but also as model 
organisms for human disease phenotypes (Mignot et al., 1991; Van Laere et 
al.,  2003;  Rubin  et  al.,  2007;  Rosengren  Pielberg  et  al.,  2008).  Thus, 
domestic  animals  are  a  complement  to  other  experimental  organisms  for 
unravelling  the  genetics  behind  simple  and  complex  traits  (Andersson, 
2009). 
  Phenotypic traits and diseases can be divided into monogenic and complex 
polygenic traits. Simple Mendelian traits are controlled by a single highly  
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penetrant locus and show a Mendelian inheritance pattern, which is either 
autosomal  or  X-linked  (recessive,  dominant  or  co-dominant),  thus  the 
relationship between the causative allele and the trait of interest is one-to-
one. In contrast, multi-factorial traits are controlled by multiple loci as well 
as environmental factors, and therefore the inheritance does not follow any 
simple Mendelian pattern. Each locus usually explains a small part of the 
phenotypic  variation.  For  example,  it  has  been  estimated  that  height  in 
humans has an 80 % heritability, however the 180 variants associated with 
height together explain merely 10 % of the genetics (Lango Allen et al., 
2010). 
Genetic trait mapping  
Genetic markers 
For most of the 20th century, whole-genome linkage or association studies 
in humans were not feasible, mainly due to too few well-defined markers 
(Lander & Schork, 1994; Hirschhorn & Daly, 2005; Altshuler et al., 2008). 
It  wasn't  until  the  1980s,  when  DNA  polymorphisms  (tandem  repeats, 
microsatellites or simple sequence repeats) were discovered throughout the 
genome, that it became possible to trace inheritance and perform whole-
genome linkage studies in humans (Botstein et al., 1980; Altshuler et al., 
2008).  In  1987  the  first  genetic  linkage  map  was  generated  with 
approximately 400 markers (Donis-Keller et al., 1987). Ten years later it was 
expanded to about 5000 markers (Dib et al., 1996). The next advance came 
with the discovery and cataloguing of large numbers of single nucleotide 
polymorphisms (SNPs) which has now been expanded to several million 
SNPs (Frazer et al., 2007). Due to their high abundance in the genome, 
biallelic  nature  and  also  the  ease  of  scoring,  SNPs  are  considered 
advantageous in whole-genome studies. 
Linkage analysis and whole-genome association mapping 
Methods for studying whole-genome genotype-phenotype correlations can 
be divided into two main types, i.e. linkage  (Figure 1A) and association 
analysis (Figure 1B) (Lander & Schork, 1994; Kruglyak, 1999; Peltonen et 
al., 2000; Hirschhorn & Daly, 2005; Altshuler et al., 2008). Both methods 
are dependent on the occurrence of recombination (meiotic cross-over). In 
linkage  analysis,  recombination  events  are  evaluated  in  a  family  under  a 
well-defined  inheritance  model.  The  family  includes  parents,  which  are 
heterozygous  for  the  trait  locus  studied,  enabling  genetic  markers  to 
segregate and to be traced over generations. Family members presenting the  
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same  phenotype  are  expected  to  share  alleles  at  markers  close  to  the 
causative  mutation.  Due  to  the  markers  proximity  to  the  disease  gene 
recombination is less likely to occur, hence the genetic markers and the 
causative alleles are linked. The power of linkage analysis depends on the 
number of informative meioses (Lander & Schork, 1994). Lod (log of odds)-
score  tests  are  used  to  provide  evidence  for  linkage  and  estimates  of 
recombination fractions. Positive lod-scores support linkage, negative lod-
scores indicate that linkage is less likely at the recombination fraction used to 
calculate the lod score.  Linkage analysis  in  humans  has proven to be an 
effective  method  for  mapping  traits  with  simple  Mendelian  inheritance 
caused  by  highly  penetrant  alleles,  where  the  relationship  between 
phenotype  and  genotype  is  one-to-one.  Disease-causing  mutations,  for 
example familial early onset forms of Alzheimer's disease and Huntington's 
disease (Peltonen et al., 2006; Bekris et al., 2010; Munoz-Sanjuan & Bates, 
2011) have been mapped utilizing this strategy. Although linkage analysis 
proved  to  be  a  successful  method  to  identify  trait  loci  with  simple 
inheritance,  the  approach  was  unsatisfactory  for  mapping  loci  underlying 
multifactorial traits in humans. When mapping complex traits assumptions 
about  the  genotype  or  the  inheritance  model  cannot  be  made,  and 
consequently the power of the analysis is decreased. Instead of using linkage 
for  mapping  complex  traits,  whole-genome  association  studies  were 
suggested during the mid 1990s (Lander, 1996; Risch & Merikangas, 1996; 
Collins et al., 1997).   
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Figure 1. Schematic overview of linkage analysis and association mapping. 
(A)  The  mode  of  inheritance  can  be  defined  by  pedigree  analysis.  The 
analysis is performed under the assumption that alleles causing a phenotypic 
trait  or  disease  will  cosegregate  with  genetic  markers  on  the  same 
chromosome.  (B)  The  allele  frequency  is  estimated  for  each  marker  in 
unrelated  individuals  and  compared  between  cases  and  controls.  Circles 
represent females and squares represent males, cases are illustrated by black 
symbols  and  controls  by  white  (figure  modified  from  Lander  &  Schork 
(1994)). 
 
In association mapping, historical recombination events that have occurred 
in the ancestors of the genotyped individuals are utilized. A prerequisite in 
association  mapping  is  that  the  markers  are  dispersed  equally  along  the 
genome, without regions of gaps. In association mapping, the association 
between  neutral  polymorphisms  (nowadays  SNPs)  and  a  certain  trait  is 
defined  using  unrelated  individuals.  Allele  frequencies  are  determined  in 
cases and compared to the allele frequency in controls. If the frequency of 
an allele is more common in the cases than the controls, it is considered to 
be associated with a certain trait. The assumption in association mapping is 
that  at  least  one  marker  will  be  in  linkage  disequilibrium  (LD)  with  a 
polymorphism affecting the trait. LD refers to the non-random association 
of two or more alleles at different loci, hence loci located in the vicinity of 
each other on the same chromosome are more likely to be in LD than loci 
on different chromosomes. The power of association mapping depends on 
the  degree  of  LD  between  the  genotyped  marker  and  the  mutation  of 
interest. Markers in proximity of each other will show stronger LD, since 
LD  decays  with  distance.  In  early  2006,  technologies  for  large-scale 
genotyping  of  large  sample  sets  enabled  genome-wide  studies.  By  2007, 
more than 150 associations between diseases and common SNPs had been 
identified,  although  the  significant  loci  usually  only  explained  a  minor  
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fraction of the phenotypic variation (Consortium, 2007; McCarthy et al., 
2008; Manolio et al., 2009).   
Utility of LD and haplotype blocks in genome-wide association studies in 
human populations 
There  are  several  reasons  why  association  mapping  may  not  identify  a 
significant signal of association, for example the study may be underpowered 
with regard to sample size and marker density. Thus, a central aspect of 
genome-wide association studies (GWAS) is to assess the minimum amount 
of SNPs to include without losing power to detect genetic variation. This 
can be defined by assessing the average extent of LD and the size of the 
haplotypes along the genome (Kruglyak, 1999; Consortium, 2005). While 
LD is the quantitative unit for how markers are linked to each other, the 
haplotype  defines  the  combination  of  alleles  at  different  loci  that  are 
inherited together. As the extent of LD and size of haplotype blocks differs 
between different ethnic groups and varies across the genome, the number 
of SNPs required in a GWAS may vary depending on the sample set. It has 
been  estimated  in  humans  that  the  size  of  average  haplotype  blocks  are 
about 11 kb in Africans and approximately 22 kb in Caucasians and Asian 
people, with 3-5 haplotypes per block (Gabriel et al., 2002; Consortium, 
2005). It has been assessed that a panel of 300,000 to 1,000,000 SNPs should 
be sufficient for most GWAS depending on the origin of the population 
studied. The International HapMap Consortium was created to generate a 
publicly available database of common human sequence variation possibly 
simplifying  study  design  when  mapping  different  traits  and  diseases  in 
humans.  Initially  common  genetic  variation  was  analysed  in  four 
geographically diverse human populations (Consortium, 2005; Frazer et al., 
2007), which was subsequently expanded to eleven populations (Altshuler et 
al., 2010). In a study of eleven well-described isolated populations, it was 
estimated  that  LD  is  considerably  higher  in  most  isolates  compared  to 
outbred populations (Service et al., 2006). 
Characteristics of isolated populations 
There are several advantages to mapping traits in isolated populations. Due 
to population bottlenecks, that can sometimes be re-occurring followed by 
periods of rapid growth, allele frequencies may change (genetic drift). As a 
consequence isolated populations may have a higher prevalence of certain 
diseases due to the enrichment of shared risk alleles (Peltonen et al., 2000). 
Thus, there is less genetic heterogeneity in an isolated population, many 
patients  share  the  same  causative  mutation  and  its  associated  haplotype  
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block. Another positive attribute lies in the reduced noise in the data set 
through the shared environmental factors applied to isolated populations. 
These populations by definition have less migration and thus more intact 
families,  often  with  good  genealogical  records  (Peltonen  et  al.,  2000). 
Finally, population stratification, which can be a major issue in the general 
population,  may  be  less  of  a  problem  when  mapping  traits  in  isolated 
populations. 
Sources to false-positive associations 
Population  stratification  by  definition  arises  when  markers  have  different 
allele frequencies in different sub-populations (Hirschhorn & Daly, 2005). 
This means that positive signals of association may describe the difference 
between  the  different  sub-populations,  rather  than  an  association  with  a 
disease trait. Family structure or cryptic relatedness further complicates any 
corrections for stratification. There are different methods implemented in 
different  softwares  enabling  the  detection  of,  and  correction  for, 
stratification as reviewed by Price et al. (2010). A possible way to avoid 
stratification is to use family-based samples. Although these sample sets may 
present other challenges such as reduced power with regard to sample size.  
  False-positive associations may also arise due to missing genotyping data. 
Some methods have a lower success rate when genotyping heterozygous 
positions,  thus  leading  to  deviations  from  Hardy-Weinberg  equilibrium 
(Lander & Schork, 1994; Hirschhorn & Daly, 2005). However, these types 
of errors are generally less likely to cause false-positive associations since it is 
expected that cases and controls will be equally affected and is therefore 
more often causing false-negative results.  
  An alternative explanation for unsuccessful association studies may lie with 
mitochondrial inheritance. In this case a trait is inherited along the maternal 
lineage,  hence  there  is  no  true  association  between  the  disease  and  the 
genetic markers of the nuclear genome.  
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Genetics of mitochondrial disorders  
Disease-causing polymorphisms of the mitochondrial genome 
The mitochondrion is an organelle located in the cytoplasm of the cell with 
many crucial functions, such as to provide the cell with energy in the form 
of  adenosine-5'-triphosphate  (ATP).  The  mitochondrion  has  its  own 
genome, referred to as the mitochondrial DNA (mtDNA). However, the 
mtDNA  is  only  about  16.6  kb  compared  to  the  nuclear  DNA  (nDNA) 
which is about 2.5 Gb in the dog.  
  The first disease-causing mutations in the human mitochondrial genome 
were identified during the late 1980s (Holt et al., 1988; Wallace et al., 1988). 
Since then, more than 550 disease-causing mutations and rearrangements 
have been associated with disorders such as cardiomyopathies, myopathies, 
diabetes and parkinsonism (Figure 2; www.mitomap.org May 2011; Ruiz-
Pesini  et  al.,  2007).  It  has  been  estimated  that  the  prevalence  of 
mitochondrial  disorders  in  the  human  population  is  1/5000,  which  is 
considered to be relatively common for a metabolic disease (Schaefer et al., 
2004). 
  Although the mitochondrial genome encodes few proteins (13 in total, 
Figure 2), the mitochondrion is a protein-rich organelle, due to the import 
of  nuclear-encoded  proteins  from  the  cellular  cytoplasm  (DiMauro  & 
Schon, 2003). Thus, there is cross talk between the two genomes, meaning 
that mitochondrial disorders may have a nuclear or mitochondrial genetic 
origin.   
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Figure  2.  Schematic  overview  of  the  human  mitochondrial  genome 
including the approximate positions of several disease-causing mutations and 
their associated disorders. Red, protein coding genes; rRNA, blue; green, 
displacement-loop;  black,  tRNA  genes  and  associated  disorders.  ECM, 
encephalomyopathy;  FBSN,  familial  bilateral  striatial  necrosis;  LOHN, 
Leber  hereditary  optic  neuropathy;  LS,  Leigh's  syndrome;  MELAS, 
mitochondrial encephalomyopathy, lactic acidosis and stroke like episodes; 
MERRF,  myoclonic  epilepsy  with  ragged-red  fibres;  MILS,  maternally 
inherited  Leigh's  syndrome;  NARP,  neuropathy,  ataxia  and  retinitis 
pigmentosa; PEO, progressive external ophthalmoplegia; PPK, palmoplantar 
keratoderma;  SIDS,  sudden  infant  death  syndrome  (www.mitomap.org; 
Ruiz-Pesini et al., 2007). 
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Three major aspects by which mitochondrial and nuclear genetics differ 
There  are  three  main  differences  between  nuclear  and  mitochondrial 
genetics (DiMauro & Schon, 2001; DiMauro & Schon, 2003; DiMauro & 
Davidzon, 2005; Taylor & Turnbull, 2005; Greaves & Taylor, 2006; Park & 
Larsson, 2011). These are: 
• Heteroplasmy and threshold effect. In contrast to nuclear encoded genes, 
which  comprise  one  maternal  and  one  paternal  allele,  there  are 
hundreds to several thousand mtDNA molecules in each cell. The 
presence of one population of identical mtDNA molecules is called 
homoplasmy, whereas the existence of two or more populations of 
mtDNA is referred to as heteroplasmy. Heteroplasmic mutations are 
harmless unless the mutant load (proportion between wild type and 
mutant  mtDNA)  exceeds  a  certain  threshold,  which  varies  for 
different mitochondrial mutations and tissues. 
• Maternal  inheritance.  Unlike  the  nDNA,  the  mtDNA  is  inherited 
strictly from the mother and transmitted along the maternal lineage, 
thus  mtDNA  lineages  are  clonal.  Paternal  mtDNA  are  degraded 
through  an  ubiquitin-mediated  process  (Sutovsky  et  al.,  1999; 
Sutovsky et al., 2000). During meiosis only a limited number of 
mtDNA  molecules  are  transmitted  to  the  progeny  due  to  a 
"bottleneck"  effect  (Jenuth  et  al.,  1996;  Cao  et  al.,  2007). 
Consequently,  the  mutant  load  may  shift  rapidly  between 
generations. 
• Random mitotic segregation  (Figure 3).  Replication  of  mtDNA  is  not 
dependent on the cell cycle. Consequently, mtDNA molecules can 
replicate many times, or not at all, during a cell cycle. The degree of 
heteroplasmy  may  shift  rapidly  between  different  cell  types  and 
tissues. This may alter the clinical phenotype in an individual with 
time.   
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Figure 3. Random mitotic segregation of mtDNA. Upon mitosis mtDNA is 
randomly transmitted to daughter cells, hence each cell displays a different 
mutant  load  and  clinical  phenotype.  The  threshold  defines  the  tolerated 
mutant load before deleterious clinical symptoms develop. Within a cell, 
light  grey  circle,  white  dots  represent  wild  type  mtDNA,  black  dots 
symbolize mutant mtDNA and the dark grey dot represents the nucleus. 
Identifying the genetic origin of a mitochondrial disorder 
Different  approaches  can  be  utilized  to  assess  the  genetic  origin  of  a 
mitochondrial disorder; (I) Relatedness of cases can be traced in a pedigree. 
If  all  cases  are  traced  back  on  the  maternal  lineage  to  the  same  female 
ancestor, there is a high probability that the disorder has a mitochondrial 
origin.  However,  due  to  the  extensive  generation  time  in  humans, 
information from pedigrees comprised of several generations is limited. (II) 
Enzyme complex activity and ATP production, or oxygen consumption, of 
the  respiratory  chain  can  be  measured.  Since  different  complexes  are 
encoded by nDNA and mtDNA, it may be possible to elucidate the origin 
of the disease and subsequently the mutation (Wibom et al., 2002). (III) In a 
situation when there is no pedigree information available and biochemical 
measurements  of  the  respiratory  chain  are  ambiguous,  perhaps  the  most 
informative  strategy  is  to  re-sequence  the  entire  mitochondrial  genome, 
which is relatively effortless due to its small size.  
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Assessing mitochondrial mutation causality 
Several criteria have been established supporting the deleterious role of a 
novel  mtDNA  mutation  (Naviaux,  2000;  DiMauro  &  Schon,  2001; 
DiMauro  &  Davidzon,  2005).  (I)  The  mutation  should  change  an 
evolutionary  and  functionally  important  site.  (II)  Cases  should  be 
heteroplasmic for the mutation, although there are exceptions (Taylor et al., 
2003; Taylor & Turnbull, 2005). (III) The severity of symptoms in a family 
should correlate with the degree of heteroplasmy. (IV) Deficiencies of the 
respiratory  chain  enzymes  or  mitochondrial  protein  synthesis  should  be 
functionally  confirmed  (V)  Histochemical  staining  should  confirm 
pathogenicity.   
  Although  many  mitochondrial  diseases  have  been  correlated  with 
mutations  of  the  mtDNA,  the  relationship  between  phenotype  and 
genotype is only partly understood (Graff et al., 2002; Taylor & Turnbull, 
2005).  This  could  be  due  to  a  variety  of  factors  including  the  different 
degrees  of  heteroplasmy  in  different  parts  of  the  organism  possibly 
fluctuating with time; diverse nuclear genetic background; interaction with 
other mitochondrial genes, as well as environmental factors. 
  Apart from sensory ataxic neuropathy, reported in this thesis, only one 
additional  spontaneously  occurring  mitochondrial  disorder  with 
comprehensive  genetics  has  been  reported  in  dogs,  canine  spongiform 
leukoencephalomyelopathy  (Li  et  al.,  2006).  However,  many  different 
mouse models for various mtDNA mutations exist (Wallace, 2001; Park & 
Larsson, 2011). 
The dog as a model in genetic trait mapping 
Population history of the domestic dog 
The domestication of the dog (Canis familiaris) from the grey wolf (Canis 
lupus) traces back at least 15,000 years, but possibly as far back as 31,000 
years (7,000-15,000 generations), and has been referred to as the first genetic 
bottleneck in dogs (Figure 4) (Lindblad-Toh et al., 2005; Vonholdt et al., 
2010). At this point dogs displayed a large range of genetic diversity and 
breeding  was  not  strongly  influenced  by  man.  Dogs  and  humans  had  a 
mutually beneficial relationship. Gradually, humans began to select dogs for 
certain traits such as desired behaviours (hunting, herding, retrieving) and 
appealing morphology (coat structure and colour, body size). Approximately 
200  years  ago  (corresponding  to  50-100  generations)  one  of  the  most 
extensive breeding experiments was initiated: breed creation, in which strict  
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breed standards were developed and applied. This was the second genetic 
bottleneck (Figure 4), selecting few founder animals of pre-breed dogs for 
creating each closed isolated population (present dog breeds). As a result we 
can  observe  reduced  variation  (phenotypic  and  genetic)  within  present 
breeds compared to that seen across breeds. As a population however, dogs 
show  more  morphological  diversity  than  any  other  domesticated  animal, 
with more than 400 breeds registered. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Population bottlenecks in the dog. The first population bottleneck 
occurred 15,000-31,000 years ago at the divergence from the wolf. At breed 
creation, the second genetic bottleneck (approximately 200 years ago) gave 
rise to pure bred dog isolates, each breed originating from few founder dogs 
(figure modified from Lindblad-Toh et al. (2005)).  
Exploring the potential of the dog in whole-genome mapping studies 
As a consequence of strict selective breeding and genetic drift due to the 
limited effective population size, unfavourable traits have become enriched 
in different breeds. These include diseases like cancers, neurological diseases 
(such  as  epilepsy),  heart  diseases,  autoimmune  and  metabolic  disorders 
(including diabetes), all of which are also common in humans (Ostrander et 
al., 2000; Patterson, 2000; Sutter & Ostrander, 2004; Lindblad-Toh et al., 
2005; Peltonen et al., 2006; Karlsson & Lindblad-Toh, 2008). The selective 
enrichment  of  risk  alleles  may  be  due  to  random  fixation  during  the 
bottleneck events, hitchhiking (disease mutations located in close vicinity to 
alleles under positive selection) and also pleiotropy (a single mutation gives 
rise  to  several  phenotypes).  The  high  prevalence  of  certain  diseases  in  a  
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limited number of breeds indicates that the causative mutation(s) occurred 
in the ancestral pre-breed dog population. Due to the limited number of 
founder animals used during breed creation it is likely that a limited number 
of disease-causing alleles have subsequently become enriched in the different 
breeds. Hence, detecting loci explaining the causality of a disease may be 
less challenging in dogs than in humans.  
  Apart from humans, dogs have the most extensive medical care as well as 
large  records  of  documented  relatedness.  During  the  last  decade  disease-
causing  mutations  of  approximately  25  Mendelian  disorders,  including 
narcolepsy,  kidney  cancer  and  copper  toxicosis,  have  been  identified 
(Mignot et al., 1991; Lin et al., 1999; Jonasdottir et al., 2000; van De Sluis et 
al., 2002; Lingaas  et al., 2003; Karlsson & Lindblad-Toh, 2008)  utilizing 
tools such as linkage, radiation hybrid and comparative maps (Mellersh et al., 
1997; Sutter & Ostrander, 2004). Developed as part of the Dog Genome 
Project,  the  relatively  recent  characterization  of  the  high  quality  dog 
genome  sequence,  7.5X  coverage,  offers  improved  possibilities  for  trait 
mapping and functional characterization in dogs (Lindblad-Toh et al., 2005). 
In addition to publishing the dog genome sequence, a comprehensive SNP 
catalogue was made available to the public, comprising of more than 2.5 
million  SNPs  scattered  along  the  genome  (approximately  1  SNP/kb). 
Moreover,  LD  and  haplotype  blocks  were  defined  within  and  between 
breeds. Consequently, within a breed haplotypes are large (0.5-1 Mb) and 
LD  is  often  extensive  (several  megabases),  about  10-100  times  more 
extensive in dogs than in humans (Sutter et al., 2004; Lindblad-Toh et al., 
2005). Between breeds, haplotypes are shorter and LD extends only tens of 
kb. This unique LD pattern is consistent with the occurrence of two distinct 
population  bottlenecks  (Lindblad-Toh  et  al.,  2005;  Karlsson  &  Lindblad-
Toh, 2008).  
  The LD pattern and haplotype structure imply that fewer individuals and 
markers are needed in dogs, compared to humans, to perform GWAS. The 
number of dogs required in GWAS varies, depending on the inheritance 
pattern (Lindblad-Toh et al., 2005; Karlsson & Lindblad-Toh, 2008). It has 
been estimated that for mapping a recessive trait with high penetrance 20 
cases and 20 controls is sufficient, whereas for a dominant trait, 50 cases and 
50 controls should provide sufficient power. Approximately 100 cases and 
100 controls are needed to detect alleles with 5-fold increased risk. It has 
been estimated that 10,000-15,000 SNPs (Lindblad-Toh et al., 2005) should 
be sufficient for most purposes, compared to 300,000 to 1,000,000 SNPs in 
humans (Gabriel et al., 2002; Consortium, 2005). Moreover, it has been 
assessed that within a breed, on average 73 % of the SNPs are informative  
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(polymorphic) with a minor allele frequency (MAF) 5-50 % (Lindblad-Toh 
et al., 2005).  
  Hence,  based  on  the  structure  of  the  dog  genome,  GWAS  should  be 
powerful for mapping both monogenic and complex traits with fewer SNPs 
and a smaller sample size compared to humans. Moreover, the strikingly 
similar clinical phenotype between dogs and humans suggest that the dog 
may become man's best friend in providing new insights into the biology of 
diseases shared by dogs and people. 
  Dogs are not only a potential model organism for mapping traits with 
nuclear origin; they also offer a model for studying spontaneously occurring 
mitochondrial  disorders.  While  the  first  mitochondrial  disease-causing 
mutations  were  identified  in  humans  more  than  two  decades  ago,  the 
advances  in  dogs  have  been  limited.  Several  clinical  characterizations 
suggesting mitochondrial origin have been published, however, only two 
have identified the causative mutation (Li et al., 2006; Paper II). Hence, the 
potential of utilizing the dog as a model for mitochondrial disorders is still in 
its infancy. 
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Aims of this Thesis 
The main objective of this thesis was to assess the potential of the dog as a 
model for mapping traits with nuclear and mitochondrial origin.  
 
The specific aims were to: 
 
(I)  Map the white spotting locus in dogs by utilizing two-stage association 
mapping  and  also  to  provide  functional  evidence  for  the  identified  coat 
colour candidate mutations. (Papers I and III) 
 
(II)  Identify  and  functionally  characterize  the  mutation  causing  sensory 
ataxic neuropathy in Golden Retrievers. (Paper II) 
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Present Studies 
MAPPING TWO TRAITS CONTROLLED BY TWO DIFFERENT 
GENOMES 
 
White spotting locus - proof-of-principle study (Papers I and III)  
Background 
The dog genome paper (Lindblad-Toh et al., 2005), including the high-
quality draft genome sequence, a dense SNP map (comprising more than 
2.5 million SNPs) as well as the structure of genetic variation in dogs, led to 
the next inevitable step of assessing the full potential of the dog as a model 
organism for genetic trait mapping. The extensive LD and large haplotype 
blocks  within  breeds  suggests  that  few  individuals  and  a  relatively  sparse 
marker set can be used to scan the genome for association in one breed. 
Based on the simulated power predictions by Lindblad-Toh et al. (2005) it 
was  estimated  that  approximately  20  affected  and  20  controls  should  be 
sufficient to map a recessive trait. The short LD and short haplotype blocks 
across breeds indicate that it should be feasible to decrease the region of 
association identified in one breed by adding additional breeds presenting 
the same phenotype and sharing the same ancestral origin for the mapped 
trait. Thus, a two-stage approach should be efficient to map trait genes in 
dogs.  
  In the first paper of this thesis we describe the development and general 
characteristics  of  the  first  generation  canine  SNP  array.  Moreover,  we 
analysed  the  previously  estimated  LD  and  haplotype  blocks  on  genome-
wide level and assessed breed relationships. To prove the efficiency of using 
the dog as a model we mapped two Mendelian traits: the extreme white 
coat colour in Boxer and the ridge in Rhodesian Ridgeback (Paper I). In  
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the third paper of this thesis, the identified candidate mutations of the white 
spotting locus were functionally evaluated and further assessed. 
Results and Discussion  
Brief summary of canine SNP arrays and assessment of LD and haplotype blocks 
In  order  to  be  able  to  perform  GWAS  in  dogs  we  developed  the  first 
generation  canine  Affymetrix  array  containing  26,578  SNPs  (27  K),  and 
evaluated its performance in GWAS. Three additional SNP arrays have been 
developed  since  this  paper  was  published,  the  50  K  (49,663  SNPs) 
Affymetrix array and two Illumina arrays, a 22 K (22,362 SNPs) and a 170 
K (174,943 markers) SNP chip. SNPs included on the four arrays have been 
chosen  to  maximize  overlap  between  arrays  potentially  allowing  meta-
analyses across different arrays and platforms. There are different advantages 
to the various designs, although all are functional for GWAS (Karlsson & 
Lindblad-Toh, 2008; Vaysse et al., 2011). Due to the 170 K Illumina arrays 
uniform genome coverage, high call rate and much higher SNP density it 
may be preferable as it, in addition, enables GWAS across breeds, as well as 
allows for mapping of selective sweeps and CNVs. 
  The  theory  of  breed  development  (Figure  4)  as  previously  reported 
suggests  that  different  haplotype  structure  should  be  found  between  and 
within breeds. We confirmed this on a genome-wide level by analysing the 
haplotype structure in 250 dogs using the 27 K array. We found that (I) 
within breeds haplotype blocks are long and LD is extensive, as compared to 
short haplotypes and LD dropping off rapidly with distance between breeds. 
(II) The genetic differentiation between breeds is high, which reflects the 
tight  bottlenecks  at  breed  creation.  (III)  We  noticed  that  there  is 
considerable  genetic  differentiation  between  geographically  separated 
populations of the same breed, and suggest that this could be explained by 
genetic drift.  
White spotting locus successfully mapped with a two-stage approach  
The  white  spotting  locus  (S)  in  dogs  was  defined  by  Little  (1957).  He 
described four different alleles: solid or wild type (S, single coloured coat 
without  spots),  Irish  spotting  (S
i,  moderate  white  spotting),  piebald  (S
p, 
extensive  white  spotting)  and  extreme  white  (S
w,  complete  white  coat) 
(Figure 5).  
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Figure 5. Coat colour phenotypes at the white spotting locus. (A) Left, flash 
Boxer (S
w/S) and right, white Boxer (S
w/S
w), (B) flash phenotype in Boxer 
(S
w/S), (C) solid Boxer (S/S). Coat colour phenotypes in other breeds. (D) 
White  Bull  Terrier  (S
w/S
w),  (E)  piebald  Fox  Terrier  (S
p/S
p),  (F)  Irish 
spotting  in  Basenji  (S
i/S
i),  (G)  solid  Rhodesian  Ridgeback  (S/S)  (figure 
modified from Paper I). 
   
In the Boxer breed two of the alleles exist: S and S
w, giving rise to three 
different phenotypes (Figure 5 a-c): solid (S/S), flash or semi-Irish (S
w/S) 
and  extreme  white  (S
w/S
w).  This  semi-dominantly  inherited  trait  will  be 
further discussed to demonstrate our two-stage strategy for trait mapping in 
dogs. 
  In the first step of our strategy we utilized ten white (S
w/S
w) and nine solid 
Boxers (S/S), taking advantage of the long haplotypes and extensive LD 
within breeds (Figure 6). With relatively few SNPs (27 K array), a genome-
wide significant peak of less than 1 Mb was identified on chromosome 20. 
The most associated SNP was within an approximately 800 kb haplotype 
block, defined by 11 SNPs. The association for this region was 1000-fold 
stronger than for any other region of the genome and the region contained 
only one gene, microphtalmia-associated transcription factor (MITF). The MITF 
gene  proved  to  be  an  excellent  candidate  since  MITF  is  a  crucial 
transcription factor affecting melanocyte migration and development. MITF  
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loss-of-function  mutations  in  humans  and  mice  usually  have  deleterious 
pleiotropic effects, affecting for example pigmentation, hearing and vision 
(Tassabehji et al., 1994; Smith et al., 2000; Steingrimsson et al., 2004). In 
dogs it seems to have a limited effect on other phenotypic traits, since only 
about  2  %  of  white  dogs  (S
w/S
w)  present  with  bilateral  deafness. 
Furthermore,  the  fact  that  other  pigmented  areas  of  white  spotted  dogs 
appear to have normal pigmentation suggests normal melanocyte function in 
melanocytes that reach the dermis. Hence, regulatory mutations of MITF 
are more plausible than coding mutations, as functional MITF is crucial for 
pigment production.  
  In  order  to  decrease  the  associated  region  in  Boxers,  we  performed 
finemapping (second stage mapping), by adding a second breed displaying 
the same phenotype, Bull Terriers (Figure 5D). In total 115 SNPs, spanning 
a region of 4.6 Mb, were genotyped in 127 Boxers and Bull Terriers (S/S, 
S
w/S and S
w/S
w). Sixty-eight SNPs were in the associated 800 kb haplotype 
and the remainder in flanking regions. First the association was performed in 
each breed separately, then the two association peaks were compared and 
the minimum shared haplotype was identified. Haplotype analysis revealed a 
102 kb region, which included two haplotype blocks with perfect genotype-
phenotype correlation in both breeds. One of the blocks (approximately 20 
kb) included the melanocyte-specific 1M promoter, crucial for melanocyte 
function, and the other (about 10 kb) contained exon 1B, which is included 
in several different MITF isoforms. Interestingly, the associated blocks were 
separated by a middle region of approximately 40 kb, which indicates a site 
of recombination.  
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Figure 6. Two-stage strategy. In the first step a trait is mapped in one breed, 
taking advantage of the long haplotype and extensive LD. A region less than 
1 Mb is identified. Additional breeds presenting with the same phenotype 
are used in the second step to reveal the ancient shared haplotypes. Thus the 
region is narrowed down to approximately 100 kb (figure modified from 
Karlsson & Lindblad-Toh (2008)).  
Candidate mutations in MITF 
To identify candidate mutations we re-sequenced two BAC clones, derived 
from the sequenced flash coloured Boxer used to produce the dog genome 
assembly. These two BAC clones represented the solid and white haplotypes 
respectively. In the 102 kb associated region we identified 124 sequence 
differences all located in non-coding regions, indicating that the extreme 
white phenotype is caused by regulatory mutation(s). Candidate mutations 
were evaluated in a larger material of white, flash and solid Boxers and Bull 
Terriers, as well as in additional solid dogs. Seventy-eight mutations were 
excluded since they were discordant with the coat colour phenotype. The 
remaining  46  were  evaluated  based  on  their  conservation  across  species, 
leaving three top candidates. (I) The first candidate was a short interspersed 
nucleotide  element  (SINE)  insertion  (SINEC-Cf  element)  located 
approximately 3 kb upstream of the melanocyte specific 1M promoter. The 
SINE was present in all white and piebald dogs (homozygous), heterozygous 
in flash Boxers and Bull Terriers and absent in Irish and solid dogs. This was 
a  plausible  candidate  since  SINE  elements  have  been  reported  to  affect 
transcriptional  regulation.  (II)  The  second  candidate  was  a  length 
polymorphism  (Lp)  of  a  short  set  of  nucleotide  repeats  located 
approximately 100 bp upstream of 1M promoter. White Boxer and Bull 
Terriers displayed alleles of 35 bp, which is 4 bp longer than the allele in  
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solid Boxers and Bull Terriers. The long variants of 35-36 bp occurred in 
white, piebald and Irish spotted breeds, whereas the short variant occurred 
in solid dogs. Interestingly, there was larger sequence variability among the 
long variant, with six alleles in six breeds, as compared to four alleles of the 
short Lp in 12 breeds. This possibly reflects positive selection for the variants 
affecting the pattern of white spotting. Moreover, the length of the Lp may 
affect the interaction of transcription factors upstream and downstream of 
the Lp. (III) The third candidate was a SNP located approximately 1.200 bp 
upstream of the 1M promoter of MITF indicated at position -1.100 bp at 
number 21 in Suppl. Table 3a in Paper I. Although it is located close to 
conserved elements, the SNP is not conserved across mammals, hence it is 
unlikely to affect this coat colour phenotype. Thus, we pursued functional 
studies to define the regulatory effects of the SINE insertion and the length 
polymorphism (Figure 7).   
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Figure  7.  Two  candidate  mutations,  a  SINE  insertion  and  a  length 
polymorphism (Lp), identified upstream of the exon 1M promoter. (A) The 
regions  defined  including  a  comparative  human-dog  alignment  over  the 
region, the 7X regulatory potential and conservation across species (UCSC 
genome browser, Human Mar. 2006 assembly, NCBI36/hg18). (B) The six 
different reporter constructs included in the Luciferase assays. Numbering 
refers to the position in the different inserts. 
Reporters suggest complex regulation of MITF 
The  functional  consequences  of  the  SINE  insertion  and  the  variable  Lp 
were investigated utilizing a Dual Luciferase Reporter  Assay System. Six 
different constructs were designed as illustrated by Figure 7: SINE + long 
Lp (LpL), corresponding to extreme white allele, no SINE + LpL, similar to  
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Irish  spotted  allele,  SINE  +  short  Lp  (LpS)  and,  no  SINE  +  LpS, 
corresponding to the solid allele. We also included two constructs with just 
the long or short Lp. The additional sequence included in the constructs, 
about 800-1000 bp upstream and downstream of the SINE, and about 1.5 
kb  upstream  and  downstream  of  the  Lp,  included  potential  regulatory 
elements in the region based on the estimated 7X regulatory potential and 
across  species  conservation  presented  in  the  UCSC  Genome  Browser 
(Kolbe  et  al.,  2004;  King  et  al.,  2005)(http://genome.uscs.edu/).  Hence 
other previously identified polymorphism were included in these flanking 
sequences, including the third top candidate SNP approximately 1.200 bp 
upstream of transcriptional start site, as shown in Table 1. 
 
Table 1. Polymorphisms in Luciferase insert design including SINE and Lp. 
Additional  polymorphisms  that  are  included  in  the  design,  that  we 
considered  unlikely  to  be  functionally  important,  are  also  presented, 
including  relative  position  in  relation  to  cap  site,  phenotype  correlation, 
reason for exclusion and numbering according to Suppl. Table 3a (Paper I). 
 
Sequence polymorphism 
Position 
relative to  
cap site, +1 
Phenotype 
correlation 
Reason  for 
exclusion 
# in Suppl. Table 
3a Paper I 
Simple repeat (12/14 bases)  -~3,450 bp  No  a  25 
SINE insertion in white  -~3,150 bp  Yes    24 
Candidate SNP  -~1,200 bp  Yes    21 
Simple repeat (9 bases)  -~700 bp  No  a  20 
SNP  -~600 bp  No  a  19 
Length polymorphism  -~100 bp  Yes    18 
Indel (2 bases)  -~60 bp  No  a  17 
SNP (novel)  + 86 bp (UTR)  Unknown     
Total size of construct (white): ~2.500 bp 
 
a, phenotype discordance 
 
SINE sequence insertion (white): ~-3.800 - ~-2.800 bp (~1.000 bp) 
Excluded region from design: ~-2.800 - ~-1.400 bp (~1.400 bp) 
Lp sequence (white): ~-1.400 - ~+90 bp (~1.500 bp) 
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Luciferase activity in the mouse melanocyte melan-a cell line and human 
melanoma cell line 624mel showed an approximately 100-fold difference in 
expression  between  the  two  cell  lines.  Due  to  suboptimal  transfection 
efficiency, results from melan-a cell line were excluded. Thus, we focused 
on interpreting the results from 624mel cell line showing higher and more 
reliable transcriptional activity in the reporters tested. 
  Reporters with the long Lp showed a considerable decrease in promoter 
activity compared to reporters with the short Lp in the 624mel cell line 
(Figure  8).  Thus,  the  long  variant  of  the  Lp  consistently  repressed  the 
reporter  activity  in  624mel  cell  line.  A  lower  activity  was  observed  in 
constructs with the SINE insertion as compared to reporters lacking the 
SINE  (Figure  8,  SINE_LpL  vs  no  SINE_LpL  and  SINE_LpS  vs  no 
SINE_LpS).  There  was  a  3-fold  difference  between  the  constructs 
representing white (SINE_LpL) and solid (no SINE_LpS) haplotypes. The 
construct  similar  to  the  Irish  spotting  haplotype  (no  SINE_LpL)  showed 
intermediate reporter activity (Figure 8).  
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Figure 8. Reporter activity in human melanoma 624mel cell line. Firefly 
luciferase  levels  normalized  against  control  vector  Renilla  luciferase. 
Measurements  were  normalized  against  the  empty  vector,  and  each 
experiment  was  repeated  three  times,  each  sample  was  measured  in 
triplicate.  Pair-wise  comparisons  of  constructs  with  long  length 
polymorphism (LpL) and short length polymorphism (LpS) show decreased 
expression in constructs with LpL. Pair-wise comparisons of constructs with 
SINE  compared  to  those  without,  show  decreased  promoter  activity  in 
reporters where the SINE is included. Capital letters above each bar show 
the  significance  (p<0.001)  in  promoter  activity  in  pairwise  comparisons 
between the different reporter constructs tested. Reporters that do not share 
a letter show a significant difference. Error bars represent standard error of 
the mean. RLU=relative luciferase unit 
 
Potential regulatory elements were analysed in regions in proximity to the 
SINE insertion and Lp using TRANSFAC Professional (Matys et al., 2006). 
Approximately 250 bp upstream of the SINE insertion a cluster of Lef1 sites 
was  identified.  Their  functionality  was  evaluated  and  confirmed  by 
electrophoretic mobility shift assay (EMSA). However, there are additional 
predicted transcriptional regulatory elements in the SINE and Lp regions 
that need to be further assessed. 
Concluding remarks of white spotting locus and MITF 
Data presented in these studies prove the efficiency of using a two-stage 
approach for mapping monogenic traits in dogs. In the first stage, a 1 Mb 
region  was  identified  in  one  breed  taking  advantage  of  the  large  breed- 
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specific haplotypes. In the second stage, an additional breed was included 
revealing  a  shared  haplotype  block,  thus  the  region  was  decreased  to 
approximately  100  kb.  Mutation  screening  including  additional  breeds 
revealed at least two plausible candidate mutations that were assessed further. 
Moreover, the current study successfully utilized the 27 K array, suggesting 
the SNP density should be sufficient in other dog genetic studies. 
  The  data  presented  in  these  studies  suggest  that  S
w,  S
p  and  S
i  do  not 
represent three independent mutations at the same locus, but rather different 
combinations  of  a  set  of  mutations  at  the  same  locus  because  of  the 
haplotype sharing we observe among the white spotting alleles. We believe 
that the combination of different regulatory mutations will define the extent 
of pigmentation. This differs from mice where most Mitf alleles represent a 
single mutation with deleterious effect, such as depigmentation, hearing loss 
and  various  eye  and  bone  diseases.  Phenotypically,  the  black-eyed  white 
Mitf mi-bw mouse model resembles the extreme white phenotype in dogs. 
This mouse phenotype is caused by an insertion in intron 3 which affects 
MITF expression and melanocyte development, causing individuals to be 
both white and deaf. The extreme white allele in dogs gives rise to a mildly 
deleterious phenotype, with approximately 2 % of the dogs presenting with 
bilateral deafness (Strain, 2004). This indicated that MITF-M expression in 
dogs  is  sufficient  for  limited  melanocyte  migration.  The  few  coloured 
patches  on  white  dogs  show  normal  pigmentation,  indicating  that  fully 
functional  MITF-M  is  expressed  in  mature  melanocytes.  Our  expression 
studies  in  human  melanoma  624mel  cell  line  revealed  that  different 
combinations of the SINE and Lp affect gene expression. However, further 
studies are necessary  to unravel the complete functional consequences  of 
these mutations.  
Future prospects 
Future studies of MITF 
The most challenging aspect in the process of unravelling the genetic cause 
of  white  spotting  in  dogs,  lies  in  the  identification  and  functional 
confirmation of the causative mutations in the MITF gene. MITF belongs 
to  the  Myc  supergene  family  of  basic  helix-loop-helix  (bHLH)-leucine 
zipper transcription factors and it is highly conserved in vertebrate species 
(Lin  &  Fisher,  2007).  In  humans,  nine  different  isoforms  have  been 
identified, mainly differing in their 5' region; exons 2 to 9 are common in 
all  nine  isoforms  (Levy  et  al.,  2006).  These  isoforms  are  expressed  in 
different tissues, MITF-M shows melanocyte-specific expression. The SINE  
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and Lp identified upstream of the MITF-M promoter are indeed probable 
candidates  but  it  may  be  possible  that  there  are  other  yet  unidentified 
polymorphisms that also contribute to the white spotting phenotype.  
  Reporters utilized in the Luciferase assays strongly support the causality of 
the  SINE  and  Lp  sequences.  However,  this  experiment  could  be 
complemented by additional constructs. It would be interesting to design 
reporters which include the entire 4 kb region upstream of promoter 1M, 
mimicking  the  "natural  situation"  in  the  white,  piebald,  Irish  and  solid 
haplotypes  and  to  use  them  in  transient  transfection  experiments  to 
functionally evaluate the entire region. If a difference in expression would 
be observed between the S
w and S
p haplotypes, it would reveal the presence 
of  additional  unidentified  regulatory  elements,  explaining  the  difference 
between S
w and S
p phenotypes which cannot be explained by the SINE and 
Lp alone. Moreover, reporters including only the SINE and Lp would show 
if  they  specifically  function  as  transcription  factor  binding  sites.  Also, 
creating a dog melanocyte cell line may be considered as it could potentially 
prove to be a more optimal system  for  further  evaluating  the  functional 
consequences of the causative white spotting polymorphisms. 
  MITF  is  an  important  developmental  gene  expressed  during  early 
embryogenesis. This complicates functional studies in tissue samples from 
dogs as one would need to obtain dog embryos, which is not a trivial task. 
Since  it  has  been  shown  that  SINEs  may  be  targeted  for  methylation 
(Arnaud et al., 2000), it would be interesting to investigate if the degree of 
methylation of the SINE insertion in S
w and S
p dogs differ. Thus, this could 
potentially explain the difference between the two phenotypes, which both 
contain the SINE and the long variant of the Lp. 
  Sequence analysis of SINE-region revealed a cluster of Lef1 sites which 
were  shown  to  form  complexes  with  nuclear  extracts  from  human 
melanoma 624mel cell line and mouse melanoma B16 cell line. Additional 
regulatory elements were predicted in both the SINE and Lp regions which 
need to be further investigated and functionally assessed. 
  A third candidate polymorphism, a SNP (nr 21 Suppl. Table 3a, Paper I), 
was considered less likely to affect the white spotting phenotype due to the 
low  degree  of  conservation  across  species.  A  possible  way  to  assess  its 
functional importance is to mutate that position in the available constructs 
that have already been tested and perform Luciferase assays and compare the 
obtained activities. If the expression in the original and mutated constructs is 
similar one can exclude the causality of this SNP in white spotting. 
  Finally, the dog model offers a complement to the already existing mouse 
models to further unravel the molecular mechanisms and cellular pathways  
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in pigmentation biology. It may also serve as a valuable model for MITF-
related  disorders  in  humans  since  for  example  deafness  (bilateral  and 
unilateral) is linked to the extreme white phenotype in dogs. 
Challenges and potential solutions in genetic trait mapping in dogs 
At  the  time  that  our  two-stage  strategy  was  published,  it  brought  great 
hopes and expectations, not only to the dog community but also to disease 
geneticists as they expected that the dog model could offer a shortcut and 
shed light on the genetics behind disorders in humans. Although the second 
expectation has been met, along the way trait mapping in dogs has proved 
to be more challenging than first anticipated. 
  GWAS are most powerful when unrelated cases and controls are used. 
The optimal sample size depends on the predicted mode of inheritance and 
how strong effects the risk factors have. Insufficient numbers of cases and 
controls  will  decrease  the  probability  of  identifying  a  true  region  of 
association. Due to the complicated family relationships in purebred dogs, 
finding and sampling a material that meet these demands can be challenging. 
Moreover, correct clinical characterization of both cases and controls is the 
first crucial step that cannot be over looked. Well-defined clinical inclusion 
and exclusion criteria for cases and controls are required to obtain this goal. 
In some projects it has been more challenging to collect healthy controls 
than  cases,  since  for  some  diseases  a  large  proportion  of  the  population 
belong  to  the  "grey-zone".  A  possible  way  to  increase  the  number  of 
samples is to include available cases and controls from different countries. In 
fact, a few years ago the LUPA consortium was initiated with the specific 
aim to unravel common human diseases using dog genetics. Partners of the 
consortium  exchange  samples  and  resources  potentially  allowing  more 
efficient progress in the different studies. 
  An additional problem in GWAS lies with population stratification. As we 
showed in Paper I, different populations from the same breed may show 
genetic differentiation. Therefore, it is important to sample geographically 
matched cases and controls. Thus, the same number of cases and controls 
with similar relatedness should be collected from different countries when 
used  in  the  same  study.  Due  to  the  difficulty  to  meet  these  aspects, 
population stratification is thoroughly investigated and the development of 
tools to correct for it is highly prioritized as it could allow us to include 
more dogs. 
  The two-stage strategy that we presented in the first paper of this thesis is 
very powerful for mapping loci that have been under strong selection, such 
as coat colour, where it is expected that mutations or combinations of old  
 
40 
risk factors are identical by descent, i.e. that they were fixed prior to breed 
creation. However in several studies of complex diseases, we have observed 
that although different breeds present similar clinical disease phenotype, they 
either: (I) could have different underlying risk loci, which may suggest that 
the risk loci arose after breed formation and possibly after the divergence of 
one single breed into different subpopulations. (II) Alternatively, the disease-
causing mutations arose in the pre-breed population and were present at low 
frequency  in  the  ancestral  population.  During  breed  formation  different 
mutations were enriched in different breeds due to the use of few founder 
dogs for each breed. The reason why we find association in different regions 
in different breeds presenting the same disease phenotype could be because 
the allele frequencies in different breeds differs or that the disease allele was 
only transmitted to a single breed in the first place.  
  It is also possible that one breed can have a sweep within another breed's 
risk-factor  peak.  Due  to  the  extensive  regions  of  homozygosity,  the 
association  may  not  be  detected.  Once  a  causative  mutation  has  been 
identified and confirmed in one breed, it would be interesting to investigate 
if the same mutation is present in breeds presenting the same phenotype but 
which show no association for that specific locus. This would reveal if the 
mutation arose before or after breed creation. Also, the risk factors between 
breeds may be shared, but the proportion of how much of a phenotypic trait 
in different breeds they explain may vary.  
  Despite these challenging aspects, several additional successful studies using 
the dog as a model to identify genetic risk factors for disease have been 
published. For example, the successful identification of risk loci underlying a 
canine  SLE-related  complex  disorder  in  Nova  Scotia  Duck  Tolling 
Retrievers (Wilbe et al., 2010), a degenerative myelopathy similar to human 
ALS (Awano et al., 2009) and Shar-Pei fever with a similar phenotype in 
humans (Olsson et al., 2011). Conclusively, the greatest lesson we can learn 
from  these  studies  is  that  each  study  offers  its  own  challenges,  and 
adjustments  have  to  be  made  accordingly,  but  a  lot  of  new  biology  is 
nonetheless learnt in an effective manner.  
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Sensory ataxic neuropathy - a mitochondrial disorder in dogs 
(Paper II) 
Background 
While  more  than  550  disease-associated  polymorphisms  of  the 
mitochondrial genome have been reported in humans (www.mitomap.org;   
Ruiz-Pesini et al., 2007) in dogs, the molecular genetic and biochemical 
data of suspected mitochondrial disorders is largely unknown. To date, there 
are only two mitochondrial disorders with mitochondrial origin in dogs for 
which disease-associated mutations have been identified and evaluated. The 
first one is canine spongiform leukoencephalomyelopathy (Li et al., 2006) 
and the second is sensory ataxic neuropathy (SAN) in Golden Retrievers 
(Paper II). 
  SAN is a recently identified neurological disorder in Golden Retrievers 
with an insidious onset between two and eleven months of age, followed by 
a  slow  progression  (Jaderlund  et  al.,  2007;  Jaderlund,  2009).  Males  and 
females are affected at similar frequency and to our knowledge, there are 
approximately 30 cases in total worldwide.  
  Sensory  ataxic  neuropathies  in  humans  are  characterized  by  loss  of 
proprioceptive  sensation,  loss  of  tendon  reflexes  whilst  muscle  mass  and 
strength is preserved (Illa et al., 2001). Dogs presenting SAN show similar 
symptoms (Jaderlund et al., 2007), they are ataxic, display postural reaction 
deficits and have absent or reduced spinal reflexes. There are no detectable 
indications of muscle atrophy or pain. Affected dogs do display  a minor 
reduction in conduction of nerve impulses in sensory nerves. Post-mortem 
examination  has  revealed  mild  degenerative  changes  in  both  central  and 
peripheral nervous systems. Thus, canine SAN may be a useful model for 
sensory ataxic neuropathies affecting humans. 
Results and Discussion 
Pedigree analysis and candidate mutation suggest mitochondrial origin of SAN 
In  early  2002,  Golden  Retrievers  presenting  a  similar  neurodegenerative 
disease  phenotype  were  brought  to  the  University  Clinic,  Swedish 
University  of  Agricultural  Sciences  (SLU),  Uppsala,  Sweden  by  their 
owners. During the next few years, 25 affected dogs were diagnosed and 
subsequently traced on the maternal lineage to the same female ancestor that 
lived  during  the  1970s.  This  suggested  a  mitochondrial  mode  of  disease 
inheritance.  The  proportion  of  affected  progeny  derived  from  female  or 
male parents representing this maternal lineage was assessed. If all cases were  
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derived from female dogs, a mitochondrial DNA (mtDNA) risk factor was 
highly probable. In total there were 272 progeny from female dogs and 177 
progeny from male dogs belonging to this maternal lineage, all 25 cases were 
among the 272 offspring derived from the females. Thus, we hypothesized 
that SAN is a neurodegenerative disorder with a mitochondrial origin.  
  By  re-sequencing  the  complete  mitochondrial  genome  (approximately 
16.6 kb) of affected dogs, close relatives (defined as first, second, third or 
fourth degree relatives), and unrelated, unaffected Golden Retrievers, a one 
base pair deletion (ΔT5304) was identified in the mitochondrial tRNA
Tyrosine 
(tRNA
Tyr)  gene  of  affected  dogs  and  their  close  relatives.  This  specific 
deletion has not been found in any other dog breed and the deleted position 
is  highly  conserved  among  vertebrates.  While  several  disease-causing 
mitochondrial  tRNA
Tyr  mutations  have  been  reported  in  humans,  none 
represents  this  specific  deletion  (Pulkes  et  al.,  2000;  Raffelsberger  et  al., 
2001; Sahashi et al., 2001; Scaglia et al., 2003). 
Evaluation of methods for quantification 
Since  clinically  healthy  relatives  tested  positive  for  this  deletion, 
heteroplasmy was strongly suspected. Due to our inability to differentiate 
between  the  mutant  load  observed  among  affected  dogs  and  healthy 
relatives, we evaluated the accuracy and resolution of two different methods: 
(I)  pyrosequencing  and  (II)  quantitative  oligonucleotide  ligation  assay 
(qOLA).  Pyrosequencing  had  been  utilized  previously  for  quantification 
purposes  of  mitochondrial  heteroplasmies  (Ronaghi  &  Elahi,  2002). 
Whereas, qOLA was recently presented by Seo et al. (2007) with the specific 
aim  of  analysing  copy  number  variations  (CNVs)  more  reliably  and 
accurately than previously reported. Thus, this method had not been used to 
define heteroplasmy in mtDNA until now. 
  By cloning amplified PCR fragments from homoplasmic wild type and 
affected  dogs,  we  created  our  own  heteroplasmic  dilution  curves  from 
homoplasmic clones. Two dilution series, defined as wide (0 % wt, 10 % wt, 
20 % wt, 30 % wt... 100 % wt) and narrow (0.5 % wt, 1 % wt, 2 % wt, 3 % 
wt... 10 % wt) allowed evaluation of the two different methods (Figure 9). 
Triplicates within one experiment showed less variation in qOLA compared 
to  pyrosequencing.  Overall,  qOLA  showed  higher  accuracy  than 
pyrosequencing and we estimated that we should be able to detect samples 
with as little as 2-3 % of wt mtDNA.  
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Figure  9.  Dilution  curves  evaluated  by  pyrosequencing  and  quantitative 
oligonucleotide ligation assay (qOLA). (A) and (B) Pyroseqencing. (C) and 
(D)  qOLA.  Wide  dilution  series  analysed  with  qOLA  (C)  shows  less 
variation with a sample of triplicates as well as more accurate quantification 
of extreme values (0 % and 100 %) as compared to (A) pyrosequencing. 
Narrow  dilution  series  of  qOLA  show  higher  accuracy  compared  to 
pyrosequencing. Error bars represent standard deviations of triplicates within 
one quantification (figure modified from Paper II). 
Assessment of mutant load and functional evaluation of candidate deletion 
Due to the higher accuracy and resolution, assessment of mutant load in 
blood samples was performed using qOLA (Figure 10). Samples from the 
following  three  groups  of  related  Golden  Retrievers  were  analysed:  (I) 
affected dogs (n=20), (II) clinically healthy close relatives such as mothers, 
grandmothers  and  siblings  of  affected  dogs  (n=13),  (III)  distant  relatives 
(n=8) descending from maternal lineages one and two generations above 
our suggested founder female. We also included healthy unrelated Golden 
Retrievers (n=71) and 86 dogs representing 18 breeds as well as six wolves. 
All unrelated dogs and wolves were homoplasmic for the wt allele, whereas 
the  remaining  three  groups  were  clearly  heteroplasmic.  Distant  relatives 
showed a large degree of variation in mutant load, ranging from 5-65 %, 
hence  the  female  we  assumed  to  be  the  founder  was  in  fact  not.  The 
affected dogs showed very low levels of the wt allele, ranging from 0-11.2  
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%. Surprisingly some clinically healthy, close relatives showed comparable 
values. Our results suggest that the tRNATyr deletion is causative, as all 
cases reported descend from the branch with the highest mutant load. The 
imperfect  correlation  between  disease  phenotype  and  heteroplasmy  in 
blood,  could  be  explained  by  the  fact  that  SAN  is  manifested  in  CNS 
(central  nervous  system)  and  not  primarily  in  blood.  Furthermore,  the 
nuclear genetic background as well as environmental factors, could influence 
the penetrance of the disease (Graff et al., 2002; Taylor & Turnbull, 2005). 
Heteroplasmy  was  also  assessed  in  tissue  samples  harvested  post-mortem 
from three affected dogs and compared to the heteroplasmy measured in 
blood.  All  tissues  showed  higher  mutant  load  compared  to  blood. 
Unfortunately, we did not have access to the corresponding tissues from 
related, clinically healthy dogs with similar mutant load in blood.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  10.  Evaluation  of  heteroplasmy  in  blood  using  quantitative 
oligonucleotide  ligation  assay.  Dark  grey  bar  (W)  represent  healthy 
unrelated Golden Retrievers (n=71). Degree of heteroplasmy is represented 
by striped bars in distant relatives, white bars represent close relatives and 
affected  dogs  are  represented  by  light  grey  bars.  There  is  an  overlap  in 
mutant load between affected Golden Retrievers and their close relatives. 
Error  bars  represent  standard  deviations  of  triplicates  within  one 
quantification (figure modified from Paper II). 
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Northern blots were used to assess the steady-state levels of tRNA
Tyr from 
tRNA extracted from the muscle tissue of two controls and three affected 
SAN dogs. Extracts from affected dogs showed 10-fold lower expression 
levels  of  tRNA
Tyr  as  compared  to  controls.  Equal  expression  of  control 
tRNAs, tRNA
Cysteine (tRNA
Cys) and tRNA
Glutamine (tRNA
Gln), were detected in 
all five dogs. The lower expression of tRNA
Tyr could possibly be explained 
by a processing defect during tRNA
Tyr formation and maturation. However, 
this  is  not very likely since  tRNA
Tyr  and  tRNA
Cys  are  transcribed  as  one 
polycistronic  precursor,  hence  processing  defects  should  affect  both. 
Moreover, one would expect the tRNA
Tyr probe to hybridize to defective or 
structurally altered tRNA
Tyr molecules, leading to the visualization of more 
than one band on the membrane. Alternatively, lower expression of tRNA
Tyr 
could be explained by increased turnover of the mutant tRNA
Tyr, which 
based on our results, is the more likely explanation. 
Functional and morphologic analyses of mitochondria 
To assess the mitochondrial ATP-production rate (MAPR) and respiratory 
chain enzyme activity, muscle tissue was collected from five affected and 
five  healthy  dogs.  In  affected  dogs,  decreased  MAPR  was  observed  in 
isolated  mitochondria,  compared  to  controls.  Respiratory  chain  enzyme 
activity was significantly decreased in complex I (-63 %), complex I-III (-53 
%) and complex IV (-59 %) in affected dogs compared to controls. There 
was no altered activity of complex II between affected and control dogs. 
Interestingly, complex II is encoded exclusively by nDNA. Measurements 
of  MAPR  and  respiratory  chain  enzyme  activity  show  consistent  results, 
indicating deficiency of complex I and IV, which are dependent of subunits 
encoded by the mtDNA. Although the clinical examination did not show 
any signs of a muscle disorder, the MAPR and respiratory chain enzyme 
activity revealed severely affected mitochondrial function in affected dogs. 
Similar  mitochondrial  dysfunction  has  been  documented  in  humans  and 
mice with mitochondrial disorders (Bindoff et al., 1991; von Döbeln et al., 
1993;  Vielhaber  et  al.,  2002;  Trifunovic  et  al.,  2004).  Measurements  of 
citrate synthase activity in muscle showed elevated activity (+47 %) in cases, 
indicating increased mitochondrial proliferation, which has been observed in 
tissues  with  respiratory  chain  enzyme  deficiencies.  It  is  believed  that  the 
increased mitochondrial proliferation is due to the inadequate energy level, 
thus  it  may  be  a  compensatory  reaction  in  affected  tissues.  One  of  the 
affected  dogs  was  indistinguishable  from  the  controls  in  the  experiments 
described above.  
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  Morphological changes were observed in muscle biopsies utilized in the 
MAPR and respiratory chain enzyme activity experiments. Four of the five 
affected dogs showed reduced COX (cytochrome c) activity as compared to 
SDH (succinate  dehydrogenase). Muscle fibres with absent COX-activity 
and red-ragged fibres are observed in humans with large-scale deletions and 
tRNA mutations in mtDNA (Bindoff et al., 1991; Vielhaber et al., 2002; 
Bourgeois & Tarnopolsky, 2004). Surprisingly, red-ragged fibres were not 
observed in SAN dogs. This could be due to the fact that SAN cases do not 
display  any  signs  of  muscle  disease.  Alternatively,  this  finding  could  be 
explained  by  the  different  muscle  composition  and  higher  mitochondrial 
density in dogs compared to humans (Wakshlag et al., 2004). Interestingly, 
mitochondrial paracrystaline inclusions were identified in the affected dog 
that was indistinguishable from the controls by MAPR and respiratory chain 
enzyme measurements. Paracrystaline inclusions are a common finding in 
adult humans presenting mitochondrial myopathies. 
Concluding remarks of SAN 
The data presented in this study provides conclusive evidence that SAN is a 
maternally inherited mitochondrial disorder caused by a one bp deletion in 
the tRNA
Tyr gene (ΔT5304). Furthermore, the mutation does not cause a 
clinical phenotype unless the mutant load is very high. Mutations of the 
mitochondrial tRNA
Tyr gene have been reported in humans, although they 
involve other positions and the patients present clinical symptoms other than 
those observed in SAN affected dogs (Pulkes et al., 2000; Raffelsberger et al., 
2001; Sahashi et al., 2001; Scaglia et al., 2003). Although mouse models of 
several mitochondrial disorders have been established, they do not always 
present  satisfying  models  for  the  corresponding  spontaneously  occurring 
mitochondrial  disease in humans. While both harbour  the corresponding 
mitochondrial mutations, the clinical symptoms and the course of the disease 
may differ considerably. However, this scenario of the same mutation and 
different  clinical  symptoms  is  not  uncommon  among  human  patients. 
Intriguingly, SAN affected dogs present strikingly similar clinical symptoms. 
Finally,  we  believe  that  SAN  in  Golden  Retrievers  may  constitute  an 
interesting model for studying human mtDNA disorders.   
  Undoubtedly, this study, as well as related studies describing the clinical 
aspects of SAN (Jaderlund et al., 2007; Jaderlund, 2009), has had a great 
impact  on  the  Swedish  Golden  Retriever  population.  Following  the 
identification of the causative mutation, we also designed a genetic test for 
SAN  and  made  this  available  to  the  public.  We  recommended  genetic 
testing of suspected SAN cases as well as potential breeding female relatives.  
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So far, blood from 15 Golden Retrievers has been tested. Four unrelated 
dogs  were  identified  as  non-carriers,  nine  maternally  related  dogs  were 
carriers and two dogs belonging to the SAN family showed a homoplasmy 
of the wt allele. Hence, we recommend testing offspring descending from 
these two females, since we cannot exclude the possibility that low levels of 
the mutant allele are present in other tissues, such as egg cells.  
Future prospects 
Challenges with mitochondrial disorders and future of SAN 
The most challenging and time consuming part of this project was to find a 
quantification method which satisfied our needs for accuracy, resolution and 
which  showed  stable and consistent  measurement. Although we found a 
method  (qOLA)  that  met  these  terms,  we  are  still  puzzled  by  the 
overlapping  groups  of  affected  dogs  and  their  close  relatives.  Imperfect 
genotype-phenotype correlations seem to be one of the greater challenges 
that mitochondrial geneticists have to solve. Thus, many questions remain 
to  be  answered,  for  example:  What  part  does  the  nuclear  genetic 
background play in the clinical penetrance of SAN? Is there a reliable way 
to identify environmental factors? 
  The primary tissues used in this study were blood and muscle, however 
SAN is manifested in the CNS, primarily in sensory neurons, and at present 
the  biological  mechanism  in  sensory  neurons  which  give  rise  to  this 
particular disease is not understood. Currently the only test we have for 
screening for SAN involves assessing the mutant load in blood or muscle 
tissue  as  a  proxy  for  CNS  affection.  Clearly  more  investigation  into 
unravelling the biological mechanism underpinning this disease of the CNS, 
primarily sensory neurons, is required. 
  There may be two possible ways to further assess the functional effect of 
this  tRNA
Tyr  deletion.  One  option  would  be  to  further  characterize  the 
mutant  tRNA
Tyr  molecule  in  vitro,  for  example  by  studying  the  codon-
anticodon binding, or the amino acylation process by which amino acids are 
attached  to  the  3'  end  of  the  tRNA  molecule.  An  alternative  or 
complementary approach would be to generate a cybrid cell line harbouring 
this specific deletion, allowing manipulation in an in vivo system.  
  Even  though  we  have  not  identified  the  corresponding  disorder  in 
humans, we still believe that SAN offers a model for studying spontaneously 
occurring mitochondrial disorders, and possibly may be utilized for testing 
different therapeutic approaches which could benefit both dogs and humans.  
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Populärvetenskaplig sammanfattning 
Kartläggning  av  gener  associerade  med  en  egenskap  (vit  päls 
och  hudfärg)  och  en  sjukdom  (sensorisk  ataktisk  neuropati) 
understryker hundens potential som modellorganism 
Bakgrund 
Sedan urminnes tider, har människan försökt att förstå hur olika egenskaper 
så som exempelvis kroppslängd kan förklaras och påverkas. Speciellt intresse 
har riktats till att förstå hur det kan komma sig att särskilda sjukdomar enbart 
drabbar vissa individer. Ibland kan detta förklaras med olika miljöfaktorer 
(t.ex. osund livsstil), men allt oftare ligger svaret i arvsmassan. 
  När det av olika anledningar är omöjligt att hitta orsaken bakom en viss 
egenskap  eller  sjukdom  hos  människor,  har  ofta  djur  nyttjats,  s.k. 
modellorganismer. De vanligaste modellorganismerna inkluderar zebrafisk, 
rundmask, bananfluga och mus. På senare tid har vi även upptäckt de stora 
möjligheter som finns med att nyttja mångfalden hos våra husdjur för att 
förstå hur arvsmassan i samverkan med miljöfaktorer påverkar egenskaper. 
Följaktligen har såväl produktionsegenskaper och sjukdomar med relevans 
för människan kartlagts genetiskt hos våra husdjur.  
  I denna avhandling beskrivs hur gener som påverkar olika egenskaper och 
sjukdomar  kan  kartläggas  genom  att  nyttja  hunden  som  modelldjur  i 
genetiska studier.  
Hunden som modelldjur 
Hunden, människans bästa vän, har en unik populationshistoria som utgörs 
av minst två s.k. flaskhalsar, som innebär att en population drastiskt reduceras 
i  antal  under  en  period  för  att  sedan  öka  igen  (Figur  4).  Den  första 
flaskhalsen inträffade när tamhunden tämjdes från vargen ca 15,000-31,000 
år sedan. Denna population bestod av individer som parade sig slumpvis och  
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kunde se väldigt olika ut. Avelsbasen var bred och variationen var stor inom 
hundpopulationen. Aveln var inte i någon större utsträckning påverkad av 
människan. Successivt började människor att välja ut hundar som uppvisade 
olika  önskade  egenskaper,  till  en  början  beteenden  som  vakt,  jakt  och 
vallning, och på senare tid även utseenden, t.ex. pälsfärg och kroppsstorlek.  
  För  ungefär  tvåhundra  år  sedan  påbörjade  människan  ett  av  de  mest 
omfattande  avelsexperimenten:  renrasavel  hos  hund.  Detta  innebar  att 
hundarna delades upp i enskilda raser och strikta avelskriterier definierades 
för varje ras. Detta var den andra flaskhalsen. Mer konkret innebar det att de 
flesta raserna baserades på väldigt få individer och variationen inom varje ras 
minskade drastiskt. Däremot uppvisar hela hundpopulationen mer variation 
än något annat husdjur, med fler än 400 raser registrerade. 
  Selektiv  renrasavel  och  genetisk  drift  (slumpmässiga  förändringar  av 
allelfrekvenser), till följd av att en liten andel av populationen nyttjas i aveln, 
har  gett  upphov  till  att  förekomsten  av  vissa  oönskade  egenskaper  och 
sjukdomar har ökat inom olika raser. Detta omfattar olika beteenden t.ex. 
aggressivitet och även sjukdomar så som cancer, diabetes och epilepsi. 
  Hundens unika populationshistoria samt dess sjukdomsbild, som ofta liknar 
människans, gör hunden till ett intressant modelldjur som kan nyttjas för att 
hitta  sjukdomsorsakande  gener.  Dessa  studier  skulle  på  sikt  kunna  hjälpa 
hundar såväl som människor. 
Delarbete 1 och 3: Kartläggning av MITF genen som ger upphov till vit pälsfärg 
hos hund bekräftar att vår två-stegs princip fungerar 
I det första delarbetet av denna avhandling beskrivs en kartläggningsmetod 
för  gener  hos  hundar  som  påverkar  olika  egenskaper  och  sjukdomar. 
Orsaken bakom vit pälsfärg och ljus hudfärg hos hund, som är en relativt 
enkel  egenskap  att  klassificera,  har  kartlagts  med  hjälp  av  en  två-stegs 
princip.  I  det  första  steget  jämfördes  arvsmassan  hos  vita  och  enfärgade 
mörka boxrar, och en omfattande region i arvsmassan som är kopplad till 
egenskapen  identifierades.  Den  begränsade  variationen  inom  en  ras 
nyttjades, och därigenom var det tillräckligt att använda endast ett litet antal 
hundar och relativt få genetiska markörer. I det andra steget analyserades den 
associerade region hos andra raser som uppvisar samma färgteckning, i denna 
studie användes bullterrier. När fler raser jämförs kan vi dra nytta av den 
omfattande  (genetiska)  variationen  mellan  raser.  Härigenom  lyckades  vi 
minska regionen i arvsmassan som ger upphov till vit pälsfärg 10-faldigt och 
genen  som  orsakar  vitfärg  kunde  identifieras  som  den  s.k.  microphtalmia-
associated transcription factor (MITF) genen. Analyser av MITF genen avslöjade 
två  potentiella  kandidatmutationer  som  utvärderades  för  att  fastställa  hur  
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mutationerna  påverkar  uttrycket  av  MITF  genen.  Denna  gen  är  även 
förknippad med bland annat avvikande pigmentering och dövhet hos mus 
och människa. Dövhet har en högre förekomst hos hundar med vit päls och 
ljus hud. 
Delarbete 2: Sensorisk ataktisk neuropati hos golden retriever orsakas av en 
mutation i den mitokondriella arvsmassan 
Den  andra  delen  (delarbete  2)  i  avhandlingen  beskriver  en  av  de  första 
mitokondriella  sjukdomarna  hos  hund.  Mitokondrier  är  organeller  som 
bland annat producerar energi (ATP) för våra celler. Mitokondrierna har 
även  en  egen  arvsmassa  som  nedärvs  på  mödernet,  dvs.  från  mor  till 
avkomma. Hos människa har fler än 550 sjukdomsorsakande mutationer i 
den  mitokondriella  arvsmassan  identifierats  och  förekomsten  av 
mitokondriella sjukdomar har uppskattats till ca 1/5000, vilket anses vara 
relativt vanligt. 
  Sensorisk  ataktisk  neuropati  (SAN)  är  en  neurologisk  sjukdom  som 
drabbar  hundar  som  tillhör  en  särskild  familj  av  rasen  golden  retriever. 
Genom att analysera familjeträd fastställdes att samtliga fall härstammar (på 
mödernet)  från  en  tik  som  levde  på  1970-talet.  Analys  av  mitokondriell 
arvsmassa  avslöjade  en  potentiell  kandidatmutation  som  utvärderades, 
varefter det fastställdes att den är sjukdomsorsakande. Omfattande analyser av 
mitokondrier bekräftade att sjukdomen har sitt ursprung i mitokondrierna. I 
samband  med  att  SAN-studien  publicerades  utvecklades  ett  genetiskt  test 
som  möjliggör  att  SAN  nu  kan  avlas  bort  från  golden  retriever 
populationen. 
Slutsats 
Dessa  två  studier  som  beskriver  kartläggningen  av  en  egenskap  och  en 
sjukdom, med ursprung i två olika arvsmassor, visar utan tvivel styrkan med 
genetiska studier på hund. Därmed har en ny roll för människans bästa vän 
etablerats som skapar goda förutsättningar att på sikt även kunna avla friskare 
hundar.  
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